Co-detection of pandemic (H1N1) 2009 virus and other respiratory pathogens.
From May through October 2009, a total of 10,624 clinical samples from 23 US states were screened for multiple respiratory pathogen gene targets. Of 3,110 (29.3%) samples positive for pandemic (H1N1) 2009 virus, 28% contained ≥ 1 other pathogen, most commonly Staphylococcus aureus (14.7%), Streptococcus pneumoniae (10.2%), and Haemophilus influenzae (3.5%).
HudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
Kassi
K
Koon
Catherine M
CM
Sanders
Jessica
J
Green
Leslie
L
Malone
Holly
H
White
Delineliz
D
Zayas
Rebecca
R
Miller
Stanley
S
Lu
Jian
J
Han
D000293:Adolescent; D000367:Age Factors; D001424:Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D006193:Haemophilus influenzae / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics / Q000302:isolation & purification*; D007251:Influenza, Human / Q000453:epidemiology*; D009305:Nasopharynx / Q000382:microbiology; D016133:Polymerase Chain Reaction; D011933:Reagent Kits, Diagnostic; D012141:Respiratory Tract Infections / Q000453:epidemiology* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000235:genetics / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000302:isolation & purification*; D014481:United States / Q000453:epidemiology
D011933:Reagent Kits, Diagnostic